Login

Healthcare

00:10:00
Revolutionizing Brain Injury Treatment: Breakthrough Trials Signal Collaborative Potential with Pharma Giants |Dr Liz Dallimore , CEO, Argenica Therapeutics Ltd.
00:10:00
Significant Developments and Growth in Arecor Therapeutics' Operations Highlighted in Year-End Trading Update | Sarah Howell , CEO, Arecor Therapeutics PLC .
00:10:00
Exploring the Evolution of Biotechnology: A Journey into RNA Medicines and Scientific Innovation |Joseph E. Payne, CEO, Arcturus Therapeutics Holdings Inc.
00:10:00
Pioneering Virology Company Aims to Develop Functional Cure for Hepatitis B and Treatments for Coronavirus Infections | William H. Collier, CEO, Arbutus Biopharma Corp.
00:10:00
Innovative Drug Delivery System for Patients with Swallowing Difficulties: Aquestive Therapeutics' Approach and Medications in Development | Daniel Barber, CEO, Aquestive Therapeutics Inc.
00:10:00
Insights from Aptos Biosciences CEO on Drug Development and Healthcare Systems at Blum Burton Conference | William Rice, CEO, Aptose Biosciences Inc .
00:10:00
CEO of Aptamer Group PLC discusses anticipation of higher revenues in the second half following the release of interim results |Dr Arron Tolley, CEO, Aptamer Group PLC.
00:10:00
Revolutionizing Therapy Adherence: The Single Pill Concept's Impact on Patient Well-being and Healthcare Costs |Karlheinz Gast, CEO, Apontis Pharma.
00:10:00
Insightful interview with a biotech CEO discussing the company's focus on antisense therapies and the potential of their lead asset in treating Duchenne Muscular Dystrophy |James Garner, CEO,Antisense Therapeutics Ltd
00:10:00
"Stories of the Exchange" features CEO of Antibiotice Iași as Guest on TV |Ioan Nani, CEO, Antibiotice Iași.
00:10:00
We aim to be one of Indias most trusted pharmaceutical company|Glenn Smith,Managing Director,Novita Healthcare
00:10:00
Building the Premier Mitochondrial Medicine Company|Magnus Hansson,CMO,NeuroVive Pharmaceutical
00:10:00
we are focused on redefining the treatment of spinal cord injury|Richard Toselli,MD,InVivo Therapeutics Holdings Corp
00:10:00
Next-generation PDT that is more effective and overcomes the many shortcomings|Mr Thian Chew,CEO,Invion Ltd
00:10:00
A new generation of vaccines within animal health|Jonas Sohlman,CEO,Intervacc
00:10:00
Develops its controlled-release and targeted-release oral solid dosage drugs based on its proprietary technology|Auwal Odidi,CEO,intellipharmaceutics international inc

© 2026 Nehu